OncoTartis, Inc. is a private biotechnology company established in 2011. The Company's founding IP came from the laboratory of Prof. Andrei Gudkov at the Roswell Park Cancer Institute (Buffalo, NY). OncoTartis has built a strong international team of collaborators, including cancer biologists from the Roswell Park Cancer Institute, unique animal models experts from the Children's Cancer Institute of Australia, and medicinal chemists from Russia. Prior to the latest fundraising round, the Company's work was funded by BioProcess Capital Ventures, a VC firm from Moscow, Russia.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 12/11/17 | $6,000,000 |
Norma Investments Pharmstandard International | undisclosed |
